Tumor tissues may have aberrant activation of de novo lipogenesis due to an overexpression of fatty acid synthase (FASN), ATP citrate lyase (ACLY), and acetyl-CoA carboxylase (ACC), which is associated with unfavorable cancer outcomes. The gene discussed is ACLY; the disease is cancer.